THREAD

About THREAD

The startup offers a remote patient research platform that integrates validated studies and connects with wearables and medical devices, facilitating seamless data transfer into existing systems. This technology enables biopharma and home health professionals to efficiently design and scale clinical research programs while ensuring compliance with data requirements.

```xml <problem> Traditional clinical research methods often face challenges in patient recruitment, engagement, and data collection, leading to increased costs and delays in study timelines. The reliance on site-based visits can limit participation, especially for individuals in remote areas or with mobility issues, hindering the diversity and representativeness of study populations. </problem> <solution> THREAD offers a comprehensive, configurable platform and consulting services designed to streamline and decentralize clinical trials, enabling more efficient and patient-centric research. The platform integrates validated studies, connects with wearables and medical devices, and facilitates seamless data transfer into existing systems. By leveraging a no-code, omni-channel technology, THREAD enables researchers to design, operate, and scale next-generation studies, including electronic clinical outcome assessments (eCOA) programs. The platform supports remote data collection, telehealth virtual visits, and AI-powered insights, enhancing patient engagement and retention while optimizing study performance. </solution> <features> - Configurable, no-code platform for rapid study design and deployment - Integrated eCOA library with over 545 pre-built, pre-validated assessments - Support for decentralized clinical trials (DCTs), hybrid studies, and traditional site-based trials - Omni-channel technology supporting web, mobile, and device-based data collection - Telehealth virtual visits with video and audio capture capabilities - AI-powered analytics for patient insights and study performance optimization - Electronic consent (eConsent) and patient onboarding tools - Integration with devices and sensors for real-time data capture - Secure and compliant data management, including configurable single sign-on (SSO) - Consulting services for study design, deployment, and support </features> <target_audience> THREAD primarily serves biopharmaceutical companies, contract research organizations (CROs), and academic research institutions seeking to optimize clinical trial efficiency, enhance patient engagement, and broaden study participation through decentralized research methods. </target_audience> ```

What does THREAD do?

The startup offers a remote patient research platform that integrates validated studies and connects with wearables and medical devices, facilitating seamless data transfer into existing systems. This technology enables biopharma and home health professionals to efficiently design and scale clinical research programs while ensuring compliance with data requirements.

Where is THREAD located?

THREAD is based in Cary, United States.

When was THREAD founded?

THREAD was founded in 2012.

How much funding has THREAD raised?

THREAD has raised $50.0M.

Location
Cary, United States
Founded
2012
Funding
$50.0M
Employees
100 employees

THREAD

10
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

The startup offers a remote patient research platform that integrates validated studies and connects with wearables and medical devices, facilitating seamless data transfer into existing systems. This technology enables biopharma and home health professionals to efficiently design and scale clinical research programs while ensuring compliance with data requirements.

threadresearch.com10K+
Founded 2012Cary, United States

Funding

No specific funding rounds found.

Total Funding

$50.0M

Team (100+)

No team information available.

Company Description

Problem

Traditional clinical research methods often face challenges in patient recruitment, engagement, and data collection, leading to increased costs and delays in study timelines. The reliance on site-based visits can limit participation, especially for individuals in remote areas or with mobility issues, hindering the diversity and representativeness of study populations.

Solution

THREAD offers a comprehensive, configurable platform and consulting services designed to streamline and decentralize clinical trials, enabling more efficient and patient-centric research. The platform integrates validated studies, connects with wearables and medical devices, and facilitates seamless data transfer into existing systems. By leveraging a no-code, omni-channel technology, THREAD enables researchers to design, operate, and scale next-generation studies, including electronic clinical outcome assessments (eCOA) programs. The platform supports remote data collection, telehealth virtual visits, and AI-powered insights, enhancing patient engagement and retention while optimizing study performance.

Features

Configurable, no-code platform for rapid study design and deployment

Integrated eCOA library with over 545 pre-built, pre-validated assessments

Support for decentralized clinical trials (DCTs), hybrid studies, and traditional site-based trials

Omni-channel technology supporting web, mobile, and device-based data collection

Telehealth virtual visits with video and audio capture capabilities

AI-powered analytics for patient insights and study performance optimization

Electronic consent (eConsent) and patient onboarding tools

Integration with devices and sensors for real-time data capture

Secure and compliant data management, including configurable single sign-on (SSO)

Consulting services for study design, deployment, and support

Target Audience

THREAD primarily serves biopharmaceutical companies, contract research organizations (CROs), and academic research institutions seeking to optimize clinical trial efficiency, enhance patient engagement, and broaden study participation through decentralized research methods.

Sources:

This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.